Table of Contents

company-logo

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics Dividend Announcement

• Viking Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Viking Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Viking Therapeutics Dividend History

Viking Therapeutics Dividend Yield

Viking Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Viking Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Viking Therapeutics Financial Ratios

P/E ratio-70.44
PEG ratio94.92
P/B ratio7.66
ROE-12.73%
Payout ratio0.00%
Current ratio36.47
Quick ratio36.47
Cash Ratio1.96

Viking Therapeutics Dividend FAQ

Does Viking Therapeutics stock pay dividends?
Viking Therapeutics does not currently pay dividends to its shareholders.
Has Viking Therapeutics ever paid a dividend?
No, Viking Therapeutics has no a history of paying dividends to its shareholders. Viking Therapeutics is not known for its dividend payments.
Why doesn't Viking Therapeutics pay dividends?
There are several potential reasons why Viking Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Viking Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Viking Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Viking Therapeutics a dividend aristocrat?
Viking Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Viking Therapeutics a dividend king?
Viking Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Viking Therapeutics a dividend stock?
No, Viking Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Viking Therapeutics stocks?
To buy Viking Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Viking Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.